Home › Funds › WEITZ INVESTMENT MANAGEMENT, INC. › LH

WEITZ INVESTMENT MANAGEMENT, INC. position in LH

LABCORP HOLDINGS INC · Health Care

WEITZ INVESTMENT MANAGEMENT, INC. reported holding 95,875 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$29.5M, representing 2.02% of its reported portfolio and ranking #16 among its reported holdings. WEITZ INVESTMENT MANAGEMENT, INC. has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)95.88K sh
Reported value held$29.54M
Portfolio Weight2.02%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WEITZ INVESTMENT MANAGEMENT, INC.'s LH position evolved

WEITZ INVESTMENT MANAGEMENT, INC. first disclosed a stake in LH in Q3 2023 at 283,350 shares (US$57.0M). The position peaked in Q4 2023 at 261,350 shares, worth US$59.4M. Across 13 filings, WEITZ INVESTMENT MANAGEMENT, INC. increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 95,875 shares valued at US$29.5M — a reduction of -3,175 shares quarter over quarter.. Notable position changes include a 36% trim in Q1 2025 (shares rose 13% over the following quarter), a 29% trim in Q4 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 283.35K $56.97M New
Q4 2023 261.35K $59.40M Reduce
Q1 2024 256.35K $56.00M Reduce
Q2 2024 241.35K $49.12M Reduce
Q3 2024 236.35K $52.82M Reduce
Q4 2024 236.18K $54.16M Hold
Q1 2025 151.18K $35.18M Reduce
Q2 2025 141.18K $37.06M Reduce
Q3 2025 139.75K $40.12M Reduce
Q4 2025 99.75K $25.03M Reduce
Q1 2026 99.05K $26.43M Reduce
Q2 2026 99.05K $27.73M Hold
Q3 2026 95.88K $29.54M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has WEITZ INVESTMENT MANAGEMENT, INC. held LH?

WEITZ INVESTMENT MANAGEMENT, INC. has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WEITZ INVESTMENT MANAGEMENT, INC.'s current position in LH?

As of Q3 2026, WEITZ INVESTMENT MANAGEMENT, INC. holds 95.88K shares of LH (LABCORP HOLDINGS INC), valued at $29.54M, representing 2.02% of its reported portfolio and ranking #16.

Has WEITZ INVESTMENT MANAGEMENT, INC. been buying or selling LH?

In the latest 13F filing (Q3 2026), WEITZ INVESTMENT MANAGEMENT, INC. reduced its position in LH. The position peaked in Q4 2023 at 261.35K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.